Beau Bassett

Head-Equity Investments chez Pura Vida Investments LLC

Profil

Mr. Beau Bassett is a Head of Therapeutics at Pura Vida Investments LLC and an Analyst at Pura Vida Investments LLC (Private Equity).
Prior to re-joining the firm in 2017, Mr. Beau was the Senior Analyst for the drug portfolio at Passaic, a healthcare dedicated pod at Millennium.
Prior to his time at Millennium, Beau was a Therapeutics Analyst at Pura Vida from January 2013 to May 2016.
For the majority of this time, he was the only Therapeutics Analyst, and worked closely with the Portfolio Manager to generate ideas, establish the risk/reward and downside risk for names in the book.
Prior to joining Pura Vida, Beau was an Equity Research Associate covering specialty pharmaceuticals at Cowen & Company.
He received a B.A.
from the University of Toronto with High Distinction.

Postes actifs de Beau Bassett

Sociétés	Poste	Début
Pura Vida Investments LLC	Head-Equity Investments	01/01/2021
Pura Vida Investments LLC (Private Equity)	Analyste en capital-investissement	-

Anciens postes connus de Beau Bassett

Sociétés	Poste	Fin
Cowen & Co. LLC	Analyste en capital-investissement	01/01/2013
Millennium Healthcare of Clifton, LLC	Analyste en capital-investissement	-

Formation de Beau Bassett

University of Toronto

Undergraduate Degree